Blood count may offer clues to treatment of Covid-19


The severity of Covid-19 illness may be influenced by what researchers call "cytokine storms".

In a new study, investigators assessed 522 Covid-19 patients, aged five days to 97 years, who were admitted to two hospitals in Wuhan, China, in December and January. The study also included a "control group" of 40 healthy people.

Compared to the control group, 76% of Covid-19 patients had significantly lower levels of T cells – a type of white blood cell that plays a crucial role in immune response against viral infections.

Patients admitted to the intensive care unit had much lower T cell counts than those who didn't require ICU care. Patients over age 60 had the lowest T cell counts, the findings showed.

Loss and exhaustion of T cells

And the T cells that did survive in Covid-19 patients were exhausted and unable to function at full capacity, the study authors said.

Covid-19 patients also had high levels of cytokines – a protein that normally helps fight off infection. Too many cytokines can prompt an excessive inflammatory response called a "cytokine storm", which causes the proteins to attack healthy cells.

That suggests the new coronavirus does not attack T cells directly. Instead, it triggers the cytokine release, which results in the loss and exhaustion of T cells, according to the authors of the study published in the journal Frontiers in Immunology.

The study results provide new clues on how to treat Covid-19, the researchers said.

"We should pay more attention to T cell counts and their function, rather than respiratory function of patients," study author Dr Yongwen Chen of Third Military Medical University in Chongqing, China, said in a journal news release.

Chen added that "more urgent, early intervention may be required in patients with low T lymphocyte counts".

In addition, he noted, future research should focus on pinpointing subgroups of T cells that may be most important in Covid-19, along with identifying drugs that boost T cell counts and functioning.

READ | South Africa starts coronavirus trial of TB vaccine

READ | The lowdown on Covid-19 treatments

READ | Nanotechnology might help fight deadly 'cytokine storm' of Covid-19

Image credit: iStock
We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.